Skip to main content

Table 2 Baseline characteristics of follow-up participants and participants lost to follow-up in the Phys-Can RCT

From: Effect of self-regulatory behaviour change techniques and predictors of physical activity maintenance in cancer survivors: a 12-month follow-up of the Phys-Can RCT

 

Follow-up participants (n = 301)

Participants lost to follow-up (n = 276)

P-value a

Groups with BCTs

Groups without BCTs

All groups

HI (n = 77)

LMI (n = 81)

HI (n = 71)

LMI (n = 72)

Age, mean (SD)

60 (12)

58 (12)

57 (11)

60 (11)

59 (12)

0.907

Women, n (%)

61 (79)

64 (79)

56 (79)

57 (79)

227 (82)

0.341

Living situation,n (%)

 Living with partner

57 (75)

63 (82)

55 (78)

54 (75)

202 (79)

0.094

Education, n (%)

 University or equivalent

45 (59)

58 (73)

49 (69)

46 (64)

150 (57)

0.070

Tobacco use,n (%)

 Former or current smoker/snus user

24 (35)

23 (32)

26 (40)

30 (44)

121 (50)

0.006

Anxiety (0–21)b, mean (SD)

5 (4)

5(4)

6 (5)

5 (4)

6 (5)

0.451

Cancer-related fatigue (4–20)b, mean (SD)

11 (4)

11 (4)

11 (5)

11 (5)

12 (4)

0.248

HRQoL (0–100)b, mean (SD)

70 (20)

66 (19)

70 (20)

68 (19)

63 (21)

0.005

Exercise self-efficacy (0–10)c, mean (SD)

6 (2)

6 (2)

6 (2)

5 (1)

5 (2)

0.055

Exercise expectations (0–10)c, mean (SD)

6 (3)

6 (3)

6 (3)

6 (3)

6 (3)

0.674

Exercise motivation (0–100)c, mean (SD)

81 (23)

80 (25)

83 (19)

81 (19)

83 (19)

0.689

Comorbidities, n (%)

 One or more

37 (53)

35 (50)

37 (60)

38 (58)

146 (62)

0.087

VO2max, mean mL/kg/min (SD)

31 (8)

31 (7)

32 (6)

30 (7)

28 (7)

< 0.001

BMI, mean kg/m2 (SD)

26 (4)

25 (4)

25 (4)

25 (4)

27 (5)

< 0.001

MVPA, median min/week (IQR)

424 (260)

429 (386)

522 (417)

437 (353)

321 (331)

< 0.001

Meeting exercise guidelinesd, n (%)

68 (99)

72 (97)

60 (98)

65 (97)

192 (91)

0.001

Diagnosis, n (%)

     

0.323

 Breast cancer

60 (78)

63 (78)

56 (79)

56 (78)

222 (80)

 

 Prostate cancer

14 (18)

15 (18)

12 (17)

15 (21)

41 (15)

 

 Colorectal cancer

3 (4)

3 (4)

3 (4)

1 (1)

13 (5)

 

Primary (neo-)adjuvant treatment, n (%)

     

0.284

 Chemotherapy

42 (55)

43 (53)

37 (52)

35 (49)

141 (59)

 

 Radiation therapy

23 (30)

27 (33)

24 (34)

26 (36)

72 (30)

 

 Endocrine therapy

12 (16)

11 (14)

10 (14)

11 (15)

27 (11)

 
  1. ap-value for differences between participants included in the analysis and those who were lost to follow-up (independent t-test or Mann-Whitney for continuous variables and Chi2 test for nominal variables),bHigher scores indicate worse outcome, cHigher scores indicate better outcome, dguidelines for cancer survivors, i.e. at least 75 min/week of vigorous intensity aerobic physical activity or 150 min/week of moderate intensity aerobic physical activity or 90 min/week of moderate-to-vigorous intensity aerobic physical activity, and/or two sessions of resistance training/week. Phys-Can Physical Training and Cancer, RCT Randomised controlled trial, BCTs self-regulatory behaviour change techniques, HI High intensity exercise, LMI Low-to-moderate intensity exercise, SD Standard deviation, HRQoL Health-related quality-of-life, VO2max Maximal oxygen uptake, BMI Body mass index, MVPA Moderate-to-vigorous intensity physical activity, IQR Interquartile range. n’s do not all sum to total due to missing data; % is of those with available data
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us